Vol. 30.Issue. 2. March - April 2025 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

3.7

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

7.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.289

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.941

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 30. Issue 2. (In progress)

(March - April 2025)

This issue is in progress but contains articles that are final and fully citable.

Concise reviews

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs

Caiyun Yang, Fengxiang Lv, Jiaqi Yang, Dawei Ding, Lina Cui, Ying Han

Full text access

Original articles

Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults

Guannan Zong, Wangjia Mao, Ming Wen, Xiaoyun Cheng, Guanghui Liu

Full text access

A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality

Shenglong Lin, Haibing Gao, Huaxi Ma, Ziyuan Liao, Dongqing Zhang, Jinshui Pan, Yueyong Zhu

Full text access

Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study

Xiumei Jiang, Pan Wang, Ke Su, Han Li, Hao Chi, Fei Wang, Yu Liu, Ke Xu

Full text access

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease

Shan Hong, Yiwei Hao, Lei Sun, Ping Li, Junru Yang, Fuyang Zhang, Lingling He, Jing Zhang, Hongshan Wei

Full text access